| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Theranostics 10 (8), 3684, 2020 | 778 | 2020 |
| Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development T Wang, C Chen, LM Larcher, RA Barrero, RN Veedu Biotechnology advances 37 (1), 28-50, 2019 | 465 | 2019 |
| Cancer stem cells: a contentious hypothesis now moving forward ML O’Connor, D Xiang, S Shigdar, J Macdonald, Y Li, T Wang, C Pu, ... Cancer letters 344 (2), 180-187, 2014 | 292 | 2014 |
| Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine D Xiang, S Shigdar, G Qiao, T Wang, AZ Kouzani, SF Zhou, L Kong, Y Li, ... Theranostics 5 (1), 23, 2015 | 256 | 2015 |
| Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides T Wang, LM Larcher, L Ma, RN Veedu Molecules 23 (10), 2564, 2018 | 231 | 2018 |
| RNA aptamers targeting cancer stem cell marker CD133 S Shigdar, L Qiao, SF Zhou, D Xiang, T Wang, Y Li, LY Lim, L Kong, L Li, ... Cancer letters 330 (1), 84-95, 2013 | 205 | 2013 |
| Cancer stem cell targeted therapy: progress amid controversies T Wang, S Shigdar, MP Gantier, Y Hou, L Wang, Y Li, H Al Shamaileh, ... Oncotarget 6 (42), 44191, 2015 | 180 | 2015 |
| Aptamers as theranostic agents: modifications, serum stability and functionalisation S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al. Shamaileh, ... Sensors 13 (10), 13624-13637, 2013 | 156 | 2013 |
| Inflammation and cancer stem cells S Shigdar, Y Li, S Bhattacharya, M O’Connor, C Pu, J Lin, T Wang, ... Cancer letters 345 (2), 271-278, 2014 | 138 | 2014 |
| Challenges and opportunities for siRNA-based cancer treatment T Wang, S Shigdar, H Al Shamaileh, MP Gantier, W Yin, D Xiang, L Wang, ... Cancer letters 387, 77-83, 2017 | 113 | 2017 |
| EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ... Theranostics 5 (12), 1456, 2015 | 113 | 2015 |
| Development of a CD63 aptamer for efficient cancer immunochemistry and immunoaffinity-based exosome isolation Z Song, J Mao, RA Barrero, P Wang, F Zhang, T Wang Molecules 25 (23), 5585, 2020 | 89 | 2020 |
| Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles L Chen, X She, T Wang, L He, S Shigdar, W Duan, L Kong Nanoscale 7 (33), 14080-14092, 2015 | 88 | 2015 |
| Aspirin-loaded nanoexosomes as cancer therapeutics PHL Tran, T Wang, W Yin, TTD Tran, TNG Nguyen, BJ Lee, W Duan International Journal of Pharmaceutics 572, 118786, 2019 | 83 | 2019 |
| Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery D Xiang, S Shigdar, AG Bean, M Bruce, W Yang, M Mathesh, T Wang, ... Theranostics 7 (17), 4071, 2017 | 83 | 2017 |
| Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery X She, L Chen, L Velleman, C Li, H Zhu, C He, T Wang, S Shigdar, ... Journal of Colloid and Interface Science 445, 151-160, 2015 | 82 | 2015 |
| Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis T Wang, L Chen, A Chikkanna, S Chen, I Brusius, N Sbuh, RN Veedu Theranostics 11 (11), 5174, 2021 | 78 | 2021 |
| Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs PHL Tran, T Wang, W Yin, TTD Tran, HT Barua, Y Zhang, SB Midge, ... International journal of pharmaceutics 566, 697-707, 2019 | 68 | 2019 |
| Pyrimidine biosynthetic enzyme CAD: its function, regulation, and diagnostic potential G Li, D Li, T Wang, S He International Journal of Molecular Sciences 22 (19), 10253, 2021 | 53 | 2021 |
| Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells H AlShamaileh, T Wang, D Xiang, W Yin, PHL Tran, RA Barrero, ... Scientific reports 7 (1), 5898, 2017 | 52 | 2017 |